Robbins Arroyo LLP: bluebird bio, Inc. (BLUE) Misled Shareholders According to Class Action
bluebird bio, Inc. (BLUE)
Last bluebird bio, inc. earnings: 2/18 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.bluebirdbio.com/investor-overview
Company Research
Source: Business Wire
SAN DIEGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Shareholder rights law firm Robbins Arroyo LLP announces that purchasers of bluebird bio, Inc. (NASDAQ: BLUE) filed a class action complaint against the company’s officers and directors for alleged violations of the Securities Exchange Act of 1934 between December 11, 2017 and November 29, 2018. bluebird bio, Inc. is a clinical-stage biotechnology company developing transformative gene therapies for genetic diseases and cancer.View this information on the law firm's Shareholder Rights Blog: https://www.robbinsarroyo.com/bluebird-bio-inc/bluebird bio Failed to Disclose Relevant Material Facts to Mislead Shareholders of Regulatory Approval Prospects According to the complaint, beginning on December 11, 2017, bluebird bio touted the efficacy and future prospects of its LentiGlobin™ gene therapy. Then, on December 1, 2018, bluebird issued a press release advising investors that it had “announced new long-term data from the completed Phase
Show less
Read more
Impact Snapshot
Event Time:
BLUE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BLUE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BLUE alerts
High impacting bluebird bio, Inc. news events
Weekly update
A roundup of the hottest topics
BLUE
News
- INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of bluebird bio, Inc. (BLUE) on Behalf of InvestorsBusiness Wire
- bluebird bio, Inc. Investigated by Shareholder Rights Advocates - Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - BLUEAccesswire
- BLUEBIRD ALERT: Bragar Eagel & Squire, P.C. is Investigating Bluebird bio Inc. on Behalf of Bluebird Stockholders and Encourages Investors to Contact the FirmGlobeNewswire
- bluebird bio, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - BLUEAccesswire
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, Inc. - BLUEPR Newswire
BLUE
Earnings
- 11/7/23 - Beat
BLUE
Sec Filings
- 3/26/24 - Form 8-K
- 3/26/24 - Form NT
- 3/18/24 - Form 8-K
- BLUE's page on the SEC website